WuXi Biologics
2025.05.29
10:42
Hong Kong stocks' innovative drug concept strengthened; WuXi Biologics rose more than 8%
The concept of innovative drugs in Hong Kong stocks strengthened, with WuXi Biologics rising by more than 8%, followed by CStone Pharmaceuticals, Corning Life Sciences, Tigermed, Zhaoyan Pharmaceuticals, Fosun Pharma and others.
09:58
The Hong Kong stock market's biotechnology sector rose, with Innovent Biologics (02126.HK) up 11.7%, WuXi Biopharmaceuticals (02268.HK) up 7.34%, WuXi Biologics (02269.HK) up 6.85%, and Junshi Biosciences (01877.HK) up nearly 6%.
2025.05.27
09:56
Hong Kong-listed pharmaceutical stocks rose, with Agilent Technologies rising more than 7%.
Hong Kong-listed pharmaceutical stocks rose, with CStone Pharmaceuticals rising more than 7%, followed by Corning Life Sciences, WuXi Biologics, WuXi AppTec, and Zhaoyan Pharmaceutical.
09:42
The Hong Kong stock market's biopharmaceutical sector strengthened, with Zai Lab (09688.HK) rising nearly 3%, WuXi Biologics (02269.HK) rising nearly 2%, and WuXi AppTec (02359.HK), Rongchang Biopharma (09995.HK) and others following suit.
2025.05.21
09:59
Hong Kong-listed pharmaceutical stocks rose, with Agilent Technologies up nearly 9%
Hong Kong-listed pharmaceutical stocks rose, with CStone Pharmaceuticals rising nearly 9%, followed by Kangfang Biopharma, 3SBio, WuXi Biologics, CSPC Pharmaceutical Group, and WuXi AppTec.
2025.05.13
09:23
Hong Kong stocks' innovative drug sector rebounded, with BeiGene rising nearly 7%
The Hong Kong stock market's innovative drug sector rebounded, with BeiGene rising nearly 7%, Rongchang Biopharma and Innovent Biologics rising more than 4%, and Shijiazhuang Pharmaceutical Group, Corning Life Sciences, and WuXi Biologics rising more than 1%.
2025.05.07
16:10
At the close of Hong Kong stocks, the Hang Seng Index closed up 0.13%, while the Tech Index closed down 0.75%; China Resources Land Development (00881.HK) rose nearly 5%, AIA Group (01299.HK) rose nearly 3%, WuXi Biologics (02269.HK) fell nearly 6.7%, while Mengniu Dairy (02319.HK) and China Biologic Products (01177.HK) both fell more than 3%.
09:44
Hong Kong stocks' innovative drug sector fell in early trading, with BeiGene falling more than 6%
The Hong Kong stock market's innovative drug sector fell in early trading, with BeiGene falling more than 6%, Rongchang Biopharma falling more than 5%, Innovent Biologics, WuXi Biologics, and Junshi Biosciences all falling.
2025.05.06
09:22
When the Hong Kong stock market opened, the Hang Seng Index opened up 0.32%, and the Tech Index opened down 0.02%; AIA Group (01299.HK) and WH Group (00288.HK) both rose by more than 3%, Chow Tai Fook (01929.HK) rose by more than 2.3%, WuXi Biologics (02269.HK) fell nearly 33%, and NetEase (09999.HK) fell nearly 2%.
2025.05.02
13:23
The Hang Seng Biotech Index continued to expand its gains in the afternoon, with WuXi AppTec (02359.HK) rising nearly 8% and WuXi Biologics (02269.HK) rising more than 6%.
2025.04.29
09:51
The Hong Kong stock market's innovative drug sector rose in early trading, with Tailing Pharmaceutical (01011.HK) rising nearly 7%, Shijiazhuang Pharmaceutical Group (01093.HK) rising more than 4%, BeiGene (06160.HK), Zhaoyan Pharmaceutical (06127.HK), and WuXi Biologics (02269.HK) all rising.
09:49
Hong Kong stocks' innovative drug sector rose in early trading, with Tailing Pharmaceutical rising nearly 7%
The Hong Kong stock market's innovative drug sector rose in early trading, with Tailing Pharmaceutical rising nearly 7%, Shijiazhuang Pharmaceutical Group rising more than 4%, BeiGene, Zhaoyan Pharmaceutical, and WuXi Biologics all rising.
2025.04.22
13:35
Hong Kong stocks' innovative drug sector continued to strengthen in the afternoon, with Innovent Biologics rising by more than 10%
The Hong Kong stock market's innovative drug sector continued to strengthen in the afternoon, with Innovent Biologics and Innovent Biologics rising by more than 10%, BeiGene rising by nearly 10%, and CSPC Pharmaceutical Group, Rongchang Biopharma, and WuXi Biologics all rising sharply.
12:01
Hong Kong Stocks Midday Review: Hang Seng Index fell 0.04%, Hang Seng Technology Index fell 0.5%
At the close of Hong Kong stocks at noon, the Hang Seng Index fell 0.04% and the Hang Seng Technology Index fell 0.5%. Gold and innovative drug sectors led the gains. Chifeng Gold and Shandong Gold rose more than 10%; Ascletis Pharmaceuticals-B rose nearly 20%, and WuXi Biologics rose more than 3%. Tongcheng Travel fell nearly 10%.
2025.04.16
11:13
Hong Kong-listed pharmaceutical stocks continued to weaken, with Ascletis Pharma (01672.HK) falling more than 12%, WuXi Biologics (02269.HK) falling more than 5%, Zai Lab (09688.HK), Zhaoyan Pharmaceutical (06127.HK) and others following suit.
Load More
Email Subscription
Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.
Weekly Highlights
According to Axios: Meta Platforms (META.O) split its artificial intelligence team into two departments.

2025-05-27

South Korea's exports fell 1.3% in May from a year earlier

2025-06-01

FF:FX Super One received another 600 pre-orders, totaling 2,500 units

2025-06-02

Tesla's (TSLA.O) sales in Sweden rose 53.7% in May from a year earlier.

2025-06-02

Nvidia CEO Jensen Huang: China's artificial intelligence market will continue to develop, with or without American chips.

2025-05-29

ASIA TECH WIRE

Grasp technology trends

Download